Market Overview

UPDATE: Bank of America Merrill Lynch Initiates Coverage on Mylan with Overweight Rating

Related MYL
US Stock Futures Down Ahead Of Industrial Production Report
Mylan In Pact With Gilead To Accelerate Access To Hepatitis C
Will Congress Scuttle the AbbVie-Shire Merger? (Fox Business)

In a report published Monday, Bank of America Merrill Lynch initiated coverage on Mylan (NASDAQ: MYL) with an Overweight rating.

BofA Merrill Lynch noted, “We initiate coverage on Mylan at OW-100%, as we see material yield and promising long-term growth prospects vs. peers within the IG Pharma subsector. Moody's and S&P upgraded Mylan to investment grade last week mainly due to its strong positioning in the generics market and favorable financial policies.”

Mylan closed on Friday at $27.11.

Latest Ratings for MYL

DateFirmActionFromTo
Sep 2014ISI GroupInitiates Coverage on
Aug 2014RBC CapitalDowngradesOutperformSector Perform
Aug 2014CitigroupMaintainsNeutral

View More Analyst Ratings for MYL
View the Latest Analyst Ratings

Posted-In: Bank of America Merrill LynchAnalyst Color Initiation Analyst Ratings

 

Related Articles (MYL)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters